The state of New York currently has 62 active clinical trials seeking participants for Arthritis research studies. These trials are conducted in various cities, including New York, Rochester, Bronx and Buffalo.
Novel Form of Acquired Long QT Syndrome
NCT04169100
Recruiting
The goal of this study is to determine whether anti-Ro/SSA antibodies are associated with acquired QT prolongation in subjects with connective tissue disease. The investigators will investigate whether gender or race influence correlation between anti-Ro antibody status and prolonged QT interval and the role of inflammatory cytokines in association with anti-Ro antibodies and QT prolongation. The investigators propose to add an additional objective to test whether QT prolongation is reversible w... Read More
Gender:
All
Ages:
Between 18 years and 89 years
Trial Updated:
04/07/2022
Locations: VA New York Harbor Healthcare System, NY and Brooklyn Campuses, New York, New York
Conditions: Long QT Syndrome, Connective Tissue Diseases, Rheumatoid Arthritis
Register for Updates
Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging
NCT05135312
Recruiting
OptiSkin is now enrolling a new study to monitor nail changes in patients with nail psoriasis treated with Enbrel® (etanercept) with optical coherence tomography (OCT).
Gender:
All
Ages:
18 years and above
Trial Updated:
12/16/2021
Locations: OptiSkin Medical, New York, New York
Conditions: Psoriasis, Psoriatic Arthritis, Psoriatic Nail
Register for Updates